Equine Rabies Immunoglobulin Market
1 Study Coverage
1.1 Equine Rabies Immunoglobulin (ERIG) Product Introduction
1.2 Market by Type
1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Market by Application
1.3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Estimates and Forecasts 2017-2028
2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Estimates and Forecasts 2017-2028
2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region
2.4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2022)
2.4.2 Global Sales Equine Rabies Immunoglobulin (ERIG) by Region (2023-2028)
2.5 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region
2.5.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2022)
2.5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers
3.1.1 Global Top Equine Rabies Immunoglobulin (ERIG) Manufacturers by Sales (2017-2022)
3.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Equine Rabies Immunoglobulin (ERIG) in 2021
3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers
3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2017-2022)
3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Equine Rabies Immunoglobulin (ERIG) Revenue in 2021
3.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type
4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Sales by Type (2017-2022)
4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Sales by Type (2023-2028)
4.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
4.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type
4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Revenue by Type (2017-2022)
4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2028)
4.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Type
4.3.1 Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2017-2022)
4.3.2 Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application
5.1.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Sales by Application (2017-2022)
5.1.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Sales by Application (2023-2028)
5.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application
5.2.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Revenue by Application (2017-2022)
5.2.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2017-2028)
5.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application
5.3.1 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2017-2022)
5.3.2 Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Type
6.1.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
6.1.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
6.2 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Application
6.2.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
6.2.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
6.3 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country
6.3.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
6.3.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Type
7.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
7.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
7.2 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Application
7.2.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
7.2.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
7.3 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country
7.3.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
7.3.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Type
8.1.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
8.1.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
8.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Application
8.2.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
8.2.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
8.3 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Region
8.3.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2028)
8.3.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Type
9.1.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
9.1.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
9.2 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Application
9.2.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
9.2.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
9.3 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Country
9.3.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
9.3.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Type
10.1.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
10.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Application
10.2.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
10.3 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Country
10.3.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Serum China
11.1.1 Serum China Corporation Information
11.1.2 Serum China Overview
11.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Serum China Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Serum China Recent Developments
11.2 Lanzhou Institute of Biological Products
11.2.1 Lanzhou Institute of Biological Products Corporation Information
11.2.2 Lanzhou Institute of Biological Products Overview
11.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lanzhou Institute of Biological Products Recent Developments
11.3 Wuhan Institute of Biological Products
11.3.1 Wuhan Institute of Biological Products Corporation Information
11.3.2 Wuhan Institute of Biological Products Overview
11.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Wuhan Institute of Biological Products Recent Developments
11.4 Premium Serums
11.4.1 Premium Serums Corporation Information
11.4.2 Premium Serums Overview
11.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Premium Serums Recent Developments
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Haffkine Bio-Pharmaceutical Corporation Information
11.5.2 Haffkine Bio-Pharmaceutical Overview
11.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Haffkine Bio-Pharmaceutical Recent Developments
11.6 Bharat Serums
11.6.1 Bharat Serums Corporation Information
11.6.2 Bharat Serums Overview
11.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bharat Serums Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Equine Rabies Immunoglobulin (ERIG) Industry Chain Analysis
12.2 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Equine Rabies Immunoglobulin (ERIG) Production Mode & Process
12.4 Equine Rabies Immunoglobulin (ERIG) Sales and Marketing
12.4.1 Equine Rabies Immunoglobulin (ERIG) Sales Channels
12.4.2 Equine Rabies Immunoglobulin (ERIG) Distributors
12.5 Equine Rabies Immunoglobulin (ERIG) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Equine Rabies Immunoglobulin (ERIG) Industry Trends
13.2 Equine Rabies Immunoglobulin (ERIG) Market Drivers
13.3 Equine Rabies Immunoglobulin (ERIG) Market Challenges
13.4 Equine Rabies Immunoglobulin (ERIG) Market Restraints
14 Key Findings in The Global Equine Rabies Immunoglobulin (ERIG) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 1500IU
Table 3. Major Manufacturers of 1000IU
Table 4. Major Manufacturers of 400IU
Table 5. Major Manufacturers of Other
Table 6. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2022) & (K Units)
Table 9. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2017-2022)
Table 10. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2023-2028) & (K Units)
Table 11. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2023-2028)
Table 12. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2017-2022)
Table 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2023-2028)
Table 16. Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers (2017-2022)
Table 18. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2017-2022)
Table 20. Equine Rabies Immunoglobulin (ERIG) Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Equine Rabies Immunoglobulin (ERIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2021)
Table 23. Equine Rabies Immunoglobulin (ERIG) Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Offered
Table 25. Date of Manufacturers Enter into Equine Rabies Immunoglobulin (ERIG) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 28. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 29. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2017-2022)
Table 30. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2023-2028)
Table 31. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2017-2022)
Table 34. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2023-2028)
Table 35. Equine Rabies Immunoglobulin (ERIG) Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 38. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 39. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2017-2022)
Table 40. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2023-2028)
Table 41. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2017-2022)
Table 44. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2023-2028)
Table 45. Equine Rabies Immunoglobulin (ERIG) Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 48. North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 49. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 52. North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 53. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (K Units)
Table 56. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2023-2028) & (K Units)
Table 57. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 60. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 61. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 64. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 65. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (K Units)
Table 68. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2023-2028) & (K Units)
Table 69. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2023-2028) & (US$ Million)
Table 107. Serum China Corporation Information
Table 108. Serum China Description and Major Businesses
Table 109. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Serum China Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Serum China Recent Developments
Table 112. Lanzhou Institute of Biological Products Corporation Information
Table 113. Lanzhou Institute of Biological Products Description and Major Businesses
Table 114. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Lanzhou Institute of Biological Products Recent Developments
Table 117. Wuhan Institute of Biological Products Corporation Information
Table 118. Wuhan Institute of Biological Products Description and Major Businesses
Table 119. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Wuhan Institute of Biological Products Recent Developments
Table 122. Premium Serums Corporation Information
Table 123. Premium Serums Description and Major Businesses
Table 124. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Premium Serums Recent Developments
Table 127. Haffkine Bio-Pharmaceutical Corporation Information
Table 128. Haffkine Bio-Pharmaceutical Description and Major Businesses
Table 129. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Haffkine Bio-Pharmaceutical Recent Developments
Table 132. Bharat Serums Corporation Information
Table 133. Bharat Serums Description and Major Businesses
Table 134. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Bharat Serums Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Equine Rabies Immunoglobulin (ERIG) Distributors List
Table 140. Equine Rabies Immunoglobulin (ERIG) Customers List
Table 141. Equine Rabies Immunoglobulin (ERIG) Market Trends
Table 142. Equine Rabies Immunoglobulin (ERIG) Market Drivers
Table 143. Equine Rabies Immunoglobulin (ERIG) Market Challenges
Table 144. Equine Rabies Immunoglobulin (ERIG) Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Equine Rabies Immunoglobulin (ERIG) Product Picture
Figure 3. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Type in 2021 & 2028
Figure 3. 1500IU Product Picture
Figure 4. 1000IU Product Picture
Figure 5. 400IU Product Picture
Figure 6. Other Product Picture
Figure 7. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application in 2021 & 2028
Figure 8. Category II Exposure
Figure 9. Category III Exposure
Figure 10. Equine Rabies Immunoglobulin (ERIG) Report Years Considered
Figure 11. Global Equine Rabies Immunoglobulin (ERIG) Sales 2017-2028 (K Units)
Figure 12. Global Equine Rabies Immunoglobulin (ERIG) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Revenue 2017-2028 (US$ Million)
Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2017-2022)
Figure 16. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2023-2028)
Figure 17. North America Equine Rabies Immunoglobulin (ERIG) Sales YoY (2017-2028) & (K Units)
Figure 18. North America Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Equine Rabies Immunoglobulin (ERIG) Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Equine Rabies Immunoglobulin (ERIG) Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Equine Rabies Immunoglobulin (ERIG) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Equine Rabies Immunoglobulin (ERIG) in the World: Market Share by Equine Rabies Immunoglobulin (ERIG) Revenue in 2021
Figure 29. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
Figure 31. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2028)
Figure 32. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 33. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2017-2028)
Figure 34. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
Figure 35. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2028)
Figure 36. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 37. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2017-2028)
Figure 38. North America Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2017-2028)
Figure 39. North America Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2017-2028)
Figure 40. U.S. Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
Figure 43. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2028)
Figure 44. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 45. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2017-2028)
Figure 46. Europe Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2017-2028)
Figure 47. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2017-2028)
Figure 48. Germany Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 49. France Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Share by Region (2017-2028)
Figure 59. China Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 62. India Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
Figure 70. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 72. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2017-2028)
Figure 74. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2017-2028)
Figure 75. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2017-2028)
Figure 84. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028) & (US$ Million)
Figure 87. Equine Rabies Immunoglobulin (ERIG) Value Chain
Figure 88. Equine Rabies Immunoglobulin (ERIG) Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Industry Market Size
